Correlation Between Dynavax Technologies and TG Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dynavax Technologies and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dynavax Technologies and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dynavax Technologies and TG Therapeutics, you can compare the effects of market volatilities on Dynavax Technologies and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dynavax Technologies with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dynavax Technologies and TG Therapeutics.

Diversification Opportunities for Dynavax Technologies and TG Therapeutics

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Dynavax and TGTX is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Dynavax Technologies and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Dynavax Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dynavax Technologies are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Dynavax Technologies i.e., Dynavax Technologies and TG Therapeutics go up and down completely randomly.

Pair Corralation between Dynavax Technologies and TG Therapeutics

Given the investment horizon of 90 days Dynavax Technologies is expected to generate 2.35 times less return on investment than TG Therapeutics. But when comparing it to its historical volatility, Dynavax Technologies is 1.96 times less risky than TG Therapeutics. It trades about 0.1 of its potential returns per unit of risk. TG Therapeutics is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  2,261  in TG Therapeutics on November 2, 2024 and sell it today you would earn a total of  1,075  from holding TG Therapeutics or generate 47.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Dynavax Technologies  vs.  TG Therapeutics

 Performance 
       Timeline  
Dynavax Technologies 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies may actually be approaching a critical reversion point that can send shares even higher in March 2025.
TG Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Dynavax Technologies and TG Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dynavax Technologies and TG Therapeutics

The main advantage of trading using opposite Dynavax Technologies and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dynavax Technologies position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.
The idea behind Dynavax Technologies and TG Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges